370 related articles for article (PubMed ID: 28552719)
21. Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease.
Ye DW; Rong XL; Xu AM; Guo J
Chin J Integr Med; 2017 Jun; 23(6):410-414. PubMed ID: 28795382
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor 21 - a key player in cardiovascular disorders?
Lenart-Lipińska M; Duma D; Hałabiś M; Dziedzic M; Solski J
Horm Mol Biol Clin Investig; 2016 Jun; 30(2):. PubMed ID: 27305706
[TBL] [Abstract][Full Text] [Related]
23. [THE ROLE OF FIBROBLAST GROWTH FACTOR 21 (FGF21) IN THE REGULATION AND CORRECTION OF CARBOHYDRATE AND LIPID METABOLISM].
Marakova EN; Bazhan NM
Ross Fiziol Zh Im I M Sechenova; 2016 Dec; 102(12):1406-16. PubMed ID: 30198244
[TBL] [Abstract][Full Text] [Related]
24. A combined docosahexaenoic acid-thyroid hormone protocol upregulates rat liver β-Klotho expression and downstream components of FGF21 signaling as a potential novel approach to metabolic stress conditions.
Vargas R; Riquelme B; Fernández J; Videla LA
Food Funct; 2017 Nov; 8(11):3980-3988. PubMed ID: 28990606
[TBL] [Abstract][Full Text] [Related]
25. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine.
Kim KH; Jeong YT; Oh H; Kim SH; Cho JM; Kim YN; Kim SS; Kim DH; Hur KY; Kim HK; Ko T; Han J; Kim HL; Kim J; Back SH; Komatsu M; Chen H; Chan DC; Konishi M; Itoh N; Choi CS; Lee MS
Nat Med; 2013 Jan; 19(1):83-92. PubMed ID: 23202295
[TBL] [Abstract][Full Text] [Related]
26. Understanding the Physiology of FGF21.
Fisher FM; Maratos-Flier E
Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
[TBL] [Abstract][Full Text] [Related]
27. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
28. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
29. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
30. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
31. Double knockout of FFAR4 and FGF21 aggravates metabolic disorders in mice.
Wei L; Ye X; Cui S; Li D; Zhu S
Int J Biol Macromol; 2023 Dec; 253(Pt 1):126553. PubMed ID: 37657572
[TBL] [Abstract][Full Text] [Related]
32. FGF21 regulates insulin sensitivity following long-term chronic stress.
Jelenik T; Dille M; Müller-Lühlhoff S; Kabra DG; Zhou Z; Binsch C; Hartwig S; Lehr S; Chadt A; Peters EMJ; Kruse J; Roden M; Al-Hasani H; Castañeda TR
Mol Metab; 2018 Oct; 16():126-138. PubMed ID: 29980484
[TBL] [Abstract][Full Text] [Related]
33. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine.
Keipert S; Ost M; Johann K; Imber F; Jastroch M; van Schothorst EM; Keijer J; Klaus S
Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E469-82. PubMed ID: 24347058
[TBL] [Abstract][Full Text] [Related]
34. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor 21 and its novel association with oxidative stress.
Gómez-Sámano MÁ; Grajales-Gómez M; Zuarth-Vázquez JM; Navarro-Flores MF; Martínez-Saavedra M; Juárez-León ÓA; Morales-García MG; Enríquez-Estrada VM; Gómez-Pérez FJ; Cuevas-Ramos D
Redox Biol; 2017 Apr; 11():335-341. PubMed ID: 28039838
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor 21: a regulator of metabolic disease and health span.
Xie T; Leung PS
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E292-E302. PubMed ID: 28559437
[TBL] [Abstract][Full Text] [Related]
37. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
38. The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases.
Nonogaki K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163521
[TBL] [Abstract][Full Text] [Related]
39. Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.
Zhang F; Yu L; Lin X; Cheng P; He L; Li X; Lu X; Tan Y; Yang H; Cai L; Zhang C
Mol Endocrinol; 2015 Oct; 29(10):1400-13. PubMed ID: 26308386
[TBL] [Abstract][Full Text] [Related]
40. The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model.
Spann RA; Morrison CD; den Hartigh LJ
Front Endocrinol (Lausanne); 2021; 12():802541. PubMed ID: 35046901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
